Alice Assinger: Recruiting PhD Students for NET-IT Doctoral Program in Vienna
Alice Assinger, Professor at the Medical University of Vienna, shared on LinkedIn:
”We’re growing – and I’m excited to announce that we are recruiting 10 PhD students for our FWF-funded doctoral program NET-IT, exploring the interplay between vascular inflammation and thrombosis.
Apply now and be part of a supportive, ambitious, and highly collaborative environment, with the opportunity to shape your own project, develop independence, and contribute to meaningful science.
What we offer:
- A stimulating and international research environment in Vienna
- Strong mentorship and career development
- Projects at the forefront of cardiovascular and thrombo-inflammatory research
Application deadline: 26.04.2026, 23:55 CET
- Visit the online application portal
- Submit your application by the deadline
- Indicate your interest in our lab and your research aspirations
More information on the PhD program and available projects.
If you’re passionate about science and eager to make an impact, we would love to hear from you.
And if you know someone who might be a great fit, please share!”
Stay updated with Hemostasis Today.
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story
-
Oct 7, 2026, 14:49Aimee Burtenshaw: The Impact of the Infected Blood Inquiry on hospital Transfusion Laboratories
-
Oct 7, 2026, 14:41Vikash Jaiswal: Does Timing Matter for Calcium in Pre-Eclampsia Prevention?
-
Oct 7, 2026, 14:34Pre-Registration Ends for Our Webinar on Pregnancy and Thrombotic Risk – World Thrombosis Day
-
Oct 7, 2026, 14:19Maha Othman: Celebrating the Opening of The Current at St. Lawrence College
-
Oct 7, 2026, 14:12Zahra Ghasemi: The Role of Recovered and Source Plasma in Plasma Fractionation
-
Oct 7, 2026, 14:09Ney Carter Borges: How ApoB and Lp(a) Shape Coronary Plaque Risk